BIOGEN INC. — Director's Dealing 2018

Sep 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2018-09-26

Reporting Person: Ehlers Michael D (EVP, Research and Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-26	Common Stock	S	1000	$350.00	Disposed	4281.171	Direct

Footnotes

F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.